Ledger.Open graph →
SEC Form D · Amendment · filed April 17, 2014

PROFECTUS BIOSCIENCES INC

Offering
$7.5M
Sold
$7.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Frederick C. Tecce · Baltimore, MDDirectorJeffrey A. Ball · Oklahoma City, OKDirectorJeffrey N. Meshulam · Baltimore, MDExec · DirectorM.G. G. Sarngaharan · Baltimore, MDDirectorMichael K. Greenebaum · Baltimore, MDDirectorThomas G. Paese · Baltimore, MDExec · DirectorAlexander G. Rich · Baltimore, MDDirectorThomas A. Lynch · Baltimore, MDDirectorBrian K. Adamsky · Baltimore, MDDirectorWilliam K. Haseltine · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗